Lantheus Holdings SG&A Expenses 2013-2024 | LNTH
Lantheus Holdings annual/quarterly sg&a expenses history and growth rate from 2013 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Lantheus Holdings sg&a expenses for the quarter ending March 31, 2024 were $0.093B, a 67.19% increase year-over-year.
- Lantheus Holdings sg&a expenses for the twelve months ending March 31, 2024 were $0.305B, a 31.49% increase year-over-year.
- Lantheus Holdings annual sg&a expenses for 2023 were $0.267B, a 14.27% increase from 2022.
- Lantheus Holdings annual sg&a expenses for 2022 were $0.234B, a 6.86% increase from 2021.
- Lantheus Holdings annual sg&a expenses for 2021 were $0.219B, a 98.62% increase from 2020.
| Lantheus Holdings Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $267 |
| 2022 | $234 |
| 2021 | $219 |
| 2020 | $110 |
| 2019 | $103 |
| 2018 | $93 |
| 2017 | $92 |
| 2016 | $75 |
| 2015 | $79 |
| 2014 | $72 |
| 2013 | $68 |
| 2012 | $70 |
| Lantheus Holdings Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | $93 |
| 2023-12-31 | $76 |
| 2023-09-30 | $73 |
| 2023-06-30 | $63 |
| 2023-03-31 | $56 |
| 2022-12-31 | $67 |
| 2022-09-30 | $49 |
| 2022-06-30 | $60 |
| 2022-03-31 | $58 |
| 2021-12-31 | $82 |
| 2021-09-30 | $46 |
| 2021-06-30 | $61 |
| 2021-03-31 | $30 |
| 2020-12-31 | $27 |
| 2020-09-30 | $30 |
| 2020-06-30 | $27 |
| 2020-03-31 | $27 |
| 2019-12-31 | $28 |
| 2019-09-30 | $28 |
| 2019-06-30 | $24 |
| 2019-03-31 | $23 |
| 2018-12-31 | $22 |
| 2018-09-30 | $24 |
| 2018-06-30 | $24 |
| 2018-03-31 | $23 |
| 2017-12-31 | $25 |
| 2017-09-30 | $22 |
| 2017-06-30 | $23 |
| 2017-03-31 | $22 |
| 2016-12-31 | $19 |
| 2016-09-30 | $19 |
| 2016-06-30 | $19 |
| 2016-03-31 | $19 |
| 2015-12-31 | $18 |
| 2015-09-30 | $18 |
| 2015-06-30 | $25 |
| 2015-03-31 | $18 |
| 2014-12-31 | |
| 2014-09-30 | $19 |
| 2014-06-30 | $18 |
| 2013-12-31 | |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $5.529B | $1.296B |
| Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $175.233B | 22.94 |
| Stryker (SYK) | United States | $129.957B | 31.13 |
| Boston Scientific (BSX) | United States | $110.003B | 35.04 |
| Medtronic (MDT) | Ireland | $108.204B | 15.64 |
| EssilorLuxottica (ESLOY) | France | $99.874B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $39.398B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 27.83 |
| ResMed (RMD) | United States | $30.257B | 28.41 |
| Koninklijke Philips (PHG) | Netherlands | $25.296B | 19.60 |
| Terumo (TRUMY) | Japan | $25.163B | 35.54 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.688B | 15.13 |
| Baxter (BAX) | United States | $16.913B | 12.02 |
| Insulet (PODD) | United States | $12.064B | 53.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.877B | 0.00 |
| Demant (WILYY) | Denmark | $10.259B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.130B | 26.59 |
| BellRing Brands (BRBR) | United States | $7.607B | 35.78 |
| GN Store Nord (GNNDY) | Denmark | $4.717B | 26.49 |
| Haemonetics (HAE) | United States | $4.448B | 21.98 |
| Perrigo (PRGO) | Ireland | $3.708B | 11.24 |
| Envista Holdings (NVST) | United States | $3.128B | 12.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.126B | 14.87 |
| QuidelOrtho (QDEL) | United States | $2.927B | 16.25 |
| Neogen (NEOG) | United States | $2.853B | 27.44 |
| TG Therapeutics (TGTX) | United States | $2.528B | 71.13 |
| ICU Medical (ICUI) | United States | $2.464B | 21.75 |
| Green Thumb Industries (GTBIF) | United States | $2.303B | 45.62 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.250B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.157B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.765B | 51.74 |
| Warby Parker (WRBY) | United States | $1.662B | 0.00 |
| InMode (INMD) | Israel | $1.576B | 8.38 |
| Verano Holdings (VRNOF) | United States | $1.342B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.331B | 9.89 |
| Owens & Minor (OMI) | United States | $1.329B | 11.58 |
| National Vision Holdings (EYE) | United States | $1.113B | 35.42 |
| AtriCure (ATRC) | United States | $1.028B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.994B | 0.00 |
| Evolus (EOLS) | United States | $0.791B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.735B | 15.65 |
| Canopy Growth (CGC) | Canada | $0.714B | 0.00 |
| Quanterix (QTRX) | United States | $0.619B | 0.00 |
| Valneva SE (VALN) | France | $0.619B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.617B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.612B | 14.39 |
| Surmodics (SRDX) | United States | $0.600B | 37.59 |
| PetIQ (PETQ) | United States | $0.594B | 19.19 |
| Jin Medical (ZJYL) | China | $0.476B | 0.00 |
| ZimVie (ZIMV) | United States | $0.444B | 37.84 |
| TerrAscend (TSNDF) | Canada | $0.434B | 0.00 |
| Biote (BTMD) | United States | $0.417B | 9.60 |
| OraSure Technologies (OSUR) | United States | $0.346B | 11.14 |
| Aurora Cannabis (ACB) | Canada | $0.337B | 0.00 |
| Cerus (CERS) | United States | $0.325B | 0.00 |
| Zynex (ZYXI) | United States | $0.318B | 43.56 |
| Viemed Healthcare (VMD) | United States | $0.273B | 27.00 |
| Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
| MacroGenics (MGNX) | United States | $0.259B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.240B | 15.11 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.179B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.178B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.153B | 73.30 |
| Veru (VERU) | United States | $0.146B | 0.00 |
| InterCure (INCR) | Israel | $0.143B | 24.08 |
| FitLife Brands (FTLF) | United States | $0.142B | 20.13 |
| Quipt Home Medical (QIPT) | United States | $0.141B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 8.30 |
| Brainsway (BWAY) | Israel | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| MariMed (MRMD) | United States | $0.082B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.043B | 2.83 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.034B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Innovative Eyewear (LUCY) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |